EP2144923
Aðferðir við meðferð þar sem notað er glýkó-pegýlerað G-CSF
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.4.2008EP published:
13.2.2013EP application number:
08744881.7
EP translation filed:
6.5.2013Grant published:
15.6.2013EPO information:
European Patent Register
Max expiry date:
31.3.2028Expiry date:
31.3.2027Next due date:
30.4.2027
Title:
METHODS OF TREATMENT USING GLYCOPEGYLATED G-CSF
Timeline
Owner
Name:
ratiopharm GmbHAddress:
Graf-Arco-Strasse 3, 89079, Ulm, DE
Inventor
Name:
ZOPF, David, A.Address:
Wayne, PA, US
Name:
LUBENAU, HeinzAddress:
Neustadt, DE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
909917 PDate:
3.4.2007Country:
US
Number:
911788 PDate:
13.4.2007Country:
US
Number:
986240 PDate:
7.11.2007Country:
US
Classification
Categories:
C07K 1/00, A61K 47/48, A61P 7/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 20.3.2013
Expires: 31.3.2014
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 19.3.2014
Expires: 31.3.2015
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 19.3.2015
Expires: 31.3.2016
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 22.3.2016
Expires: 31.3.2017
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 21.3.2017
Expires: 31.3.2018
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 21.3.2018
Expires: 31.3.2019
Payer: G. H. Sigurgeirsson
Number: 12
Paid: 20.3.2019
Expires: 31.3.2020
Payer: G. H. Sigurgeirsson
Number: 13
Paid: 19.3.2020
Expires: 31.3.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 14
Paid: 12.4.2021
Expires: 31.3.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 15
Paid: 12.4.2022
Expires: 31.3.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 16
Paid: 25.3.2023
Expires: 31.3.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 20.3.2024
Expires: 31.3.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 24.3.2025
Expires: 31.3.2026
Payer: Árnason Faktor ehf.
Number: 19
Paid: 20.4.2026
Expires: 31.3.2027
Payer: Árnason Faktor ehf.